This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.
Age ≥ 18 years old;
Chest CT indicates pulmonary nodules, highly suspected of being malignant;
Size of pulmonary nodules: 8 mm < maximum diameter ≤ 30 mm, and the number of pulmonary nodules requiring intervention ≤ 3;
Preoperative imaging evaluation indicates no clear lymph node metastasis or distant metastasis (cT1N0M0);
Patients who cannot tolerate general anesthesia due to advanced age or severe cardiopulmonary diseases, or other reasons;
The target nodule has been diagnosed as a malignant tumor or metastasis;
Patients with severe bleeding tendency or uncorrectable coagulation disorder (platelet count < 50×10^9 /L, prothrombin time > 18s, prothrombin activity < 40%);
Severe pulmonary fibrosis and pulmonary hypertension;